Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KSB3.F
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Tuesday for KSB SE & Co. KGaA stock after losing 0.327%
(Updated on May 14, 2024)

Buy or Hold candidate since Mar 25, 2024 Gain 3.74% PDF

The KSB SE & Co. KGaA stock price fell by -0.327% on the last day (Tuesday, 14th May 2024) from 612.00€ to 610.00€. During the last trading day the stock fluctuated 1.32% from a day low at 608.00€ to a day high of 616.00€. The price has fallen in 6 of the last 10 days and is down by -1.61% for this period. Volume has increased on the last day by 27 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 287 shares were bought and sold for approximately 175.07€ thousand.

The stock lies in the middle of a strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 11.02% during the next 3 months and, with a 90% probability hold a price between 664.06€ and 702.07€ at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

KSB3.F Signals & Forecast

A sell signal was issued from a pivot top point on Thursday, May 02, 2024, and so far it has fallen -2.24%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). KSB SE & Co. KGaA gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". Some positive signals were issued as well, and these may have some influence on the near short-term development. The KSB SE & Co. KGaA stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately 613.71€. On a fall, the stock will find some support from the long-term average at approximately 609.09€. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. The stock had a Golden Star Signal on Friday, March 22, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star

The stock had a Golden Star Signal on Friday, March 22, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for KSB SE & Co. KGaA stock

KSB SE & Co. KGaA finds support from accumulated volume at 608.00€ and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved 8.00€ between high and low, or 1.32%. For the last week the stock has had daily average volatility of 1.18%.

Our recommended stop-loss: 587.44€ (-3.70%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 8 days ago.)

Trading Expectations (KSB3.F) For The Upcoming Trading Day Of Wednesday 15th

For the upcoming trading day on Wednesday, 15th we expect KSB SE & Co. KGaA to open at 611.33€, and during the day (based on 14 day Average True Range), to move between 600.43€ and 619.57€, which gives a possible trading interval of +/-9.57€ (+/-1.57%) up or down from last closing price. If KSB SE & Co. KGaA takes out the full calculated possible swing range there will be an estimated 3.14% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at 612.00€ (0.33%) than the support at 608.00€ (0.33%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is KSB SE & Co. KGaA stock A Buy?

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

Current score: 1.199 Buy Candidate Unchanged

Predicted Opening Price for KSB SE & Co. KGaA of Wednesday, May 15, 2024

Fair opening price May 15, 2024 Current price
611.33€ ( 0.219%) 610.00€

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KSB3.F

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 619.33 1.53 %
R2 616.28 1.03 %
R1 614.39 0.720 %
Current price: 610.00
Support S1 608.28 -0.282 %
S2 606.39 -0.592 %
S3 603.33 -1.09 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 620.00 1.64 %
R2 616.00 0.98 %
R1 612.00 0.328 %
Current price 610.00
Support S1 608.00 -0.328%
S2 602.00 -1.31%
S3 572.00 -6.23%

KSB3 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 09, 2024 May 09, 2024 May 13, 2024 26.26€ 0%
2 May 05, 2023 May 05, 2023 May 05, 2023 19.76€ 0%
3 May 06, 2022 May 06, 2022 May 06, 2022 12.26€ 0%
4 May 07, 2021 May 07, 2021 May 07, 2021 4.26€ 0%
5 May 14, 2020 May 14, 2020 May 14, 2020 8.76€ 0%

FAQ

What is the symbol for KSB SE & Co. KGaA Stock and on which exchange is it traded?
The symbol for KSB SE & Co. KGaA is KSB3.F and it is traded on the FRA (Frankfurt Stock Exchange).

Should I buy or sell KSB SE & Co. KGaA Stock?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

How to buy KSB SE & Co. KGaA Stock?
KSB SE & Co. KGaA Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy KSB SE & Co. KGaA Stock.

What's the current price of KSB SE & Co. KGaA Stock?
As of the end of day on the May 14, 2024, the price of an KSB SE & Co. KGaA (KSB3.F) share was 610.00€.

What is the 52-week high and low for KSB SE & Co. KGaA Stock?
The 52-week high for KSB SE & Co. KGaA Stock is 630.00€ and the 52-week low is 476.00€.

What is the market capitalization of KSB SE & Co. KGaA Stock?
As of the May 14, 2024, the market capitalization of KSB SE & Co. KGaA is 1.112B.

When is the next earnings date for KSB SE & Co. KGaA?
The upcoming earnings date for KSB SE & Co. KGaA is Jul 31, 2024.
Click to get the best stock tips daily for free!

About KSB SE & Co. KGaA

KSB SE & Co. KGaA Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... KSB3.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT